Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „tumour“
Suchtreffer
Begriffe & Kennungen
Caelyx pegylated liposomal · 4.8 · In patients with solid tumours, including a subset of patients with breast and ovarian cancers, treated at a d
Eintrag öffnenCalquence · 4.8 · Lymphocytosis Uncommon (0.5) 0.3 Metabolism and Tumour Lysis Syndrome Uncommon (0.5) 0.4 nutrition disorders
Eintrag öffnenCalquence · 4.8 · Lymphocytosis Uncommon (0.5) 0.3 Metabolism and Tumour Lysis Syndrome Uncommon (0.5) 0.4 nutrition disorders
Eintrag öffnenCentral primitive neuroectodermal tumor
Eintrag öffnenCeplene · 4.8 · 8 Other oncology (advanced tumour) studies
Eintrag öffnenColumvi · 4.8 · Among the 11 patients who experienced Grade ≥ 2 tumour flare, 2 patients (18.2%) received analgesics, 6 patien
Eintrag öffnenColumvi · 4.8 · Tumour flare Tumour flare was reported in 11.7% of patients who received Columvi monotherapy, including Grade
Eintrag öffnenColumvi · 4.8 · Tumour lysis syndrome TLS was reported in 2 patients (1.4%) who received Columvi monotherapy and was Grade 3 i
Eintrag öffnenCyramza · 4.3 · For patients with NSCLC, ramucirumab is contraindicated where there is tumour cavitation or tumour involvement
Eintrag öffnenDegevma · 4.8 · In a long-term phase II open-label clinical trial in patients with giant cell tumour of bone (study 6, see sec
Eintrag öffnenDegevma · 4.8 · In patients with giant cell tumour of bone, incidence of new malignancy, including malignancies involving the
Eintrag öffnenDegevma · 4.8 · In two phase II single-arm clinical trials in patients with giant cell tumour of bone, hypocalcaemia was repor
Eintrag öffnenDrovelis · 4.8 · 16 Hypertension; Liver tumours; Occurrence or deterioration of conditions for which association with CHC
Eintrag öffnenEbvallo · 4.8 · Tumour flare reaction (TFR) TFR was reported in 1 patient (1%). The event was Grade 3 and the patient recovere
Eintrag öffnenEinseitiges Fibrom
Eintrag öffnenElonva · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. Tumours of the
Eintrag öffnenEmbryonal neoplasm
Eintrag öffnenEndolymphatic sac tumor
Eintrag öffnenEnhertu · 4.8 · 13 l For all tumour types at 5.4 mg/kg and all tumour types at 6.4 mg/kg, includes abdominal discomfort, gastr
Eintrag öffnenEnhertu · 4.8 · 14 In patients treated with Enhertu 6.4 mg/kg in clinical studies across multiple tumour types (n = 1133), ILD
Eintrag öffnen